Chloe Capital Portfolio Company Spotlight: Health Care Originals
Check out the next edition of our new series spotlighting our remarkable portfolio companies and the work they are doing to disrupt their industries!
Today we want to highlight Sharon Samjitsingh, CEO and Co-Founder of Health Care Originals – the first asthma and COPD digital health solution and wearable to be validated by the Validation Institute..
Read on to learn more about Sharon and Health Care Originals (HCO)!
đź©ş What They Do: Nearly 50 million Americans have Asthma, COPD, or both, and the costs of care keep rising. Health Care Originals is the first clinically-validated platform that enables patients to take control of their respiratory help. For health plans and employers, their platform reduces costs and increases member engagement, resulting in significant ROI per patient. For users, their personalized care model leads to fewer attacks, flare ups, and hospital visits.
🩺 Why They Do It: A proven leader in scaling businesses globally, Sharon has driven 20X revenue growth and managed a $150M innovation portfolio. Sharon started Health Care Originals because of her personal experience with asthma and seeing how it not only impacted her quality of life, but also those around her. After an early pivot, the team began to develop and deploy Nightingale, and within 6 months, the improvements in people’s lives, symptoms, and health were remarkable. Just recently Health Care Originals received confirmation from the Validation Institute that their program significantly improves users health-related quality of life. Sharon says it best herself “while our story isn’t finished, all of the roadside signs are pointing in the right direction”.
🩺 How We Met: When Chloe Capital launched Fund I, Sharon was one of the first pitches we heard. Chloe’s mission of inclusive ecosystem building deeply resonated and she knew she wanted to be a part of the movement. As Sharon says, “when we have our exit, I intend to invest”, an example of our founder to funder model in action.
🩺 Chloe Effect: Health Care Originals has both benefited from and given back to the Chloe ecosystem. Sharon thanks the Chloe team for “believing in us early on in our pivot, and always [being] willing to make introductions within their network”. At the same time, they actively engage with the other Chloe’s through the Slack channel and portfolio AMA sessions.
🩺 What is Next for HCO: Health Care Originals just launched their WeFunder campaign and has raised more than $125k in 7 days. They are on a mission to transform the $83B respiratory care market by making the management of asthma and COPD seamless. They’ve proven product-market fit and are well on their way to becoming the leading platform in respiratory care. If you’re interested in participating in their community round, and at a stage usually reserved for venture capitalists, you can reserve your investment here https://wefunder.com/hco.
Important legal disclosures can be found here https://help.wefunder.com/testing-the-waters-legal-disclosure
Learn more about Health Care Originals at https://healthcareoriginals.com/